Redwood Pharma
1,185 SEK +4,41%1 investor følger denne virksomhed
Redwood Pharma is a pharmaceutical company. The main focus is on the production of ophthalmic pharmaceuticals. The products contain active substances that are used in the treatment of dry eye disease (DED), characterised by dryness, pain, and burning. The disorder is caused by inflammation due to dysfunction of the glands as well as by the usage of contact lenses. The company is based in Stockholm.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
REDW
Daglig lav / høj pris
1,115 / 1,25
SEK
Markedsværdi
3,15 mio. SEK
Aktieomsætning
38,66 t SEK
Volumen
34 t
Finanskalender
Delårsrapport
29.08.2024
Delårsrapport
13.11.2024
Årsrapport
12.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Bank of New York Mellon SA/NV, W8IMY | 4,4 % | 4,4 % |
Avanza Pension | 4,3 % | 4,3 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Redwood Pharma provides an update on the process for divesting the company's assets
Redwood Pharma provides an update on the company's future
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools